Motoric cognitive risk (MCR) syndrome is a cognitive-motor syndrome associated with increased risk of transition to dementia. The clinical phenotype of MCR is not yet established.
Objective:
To systematically assess clinical gait abnormalities in older adults with MCR.
Methods:
Of the 522 community-dwelling non-demented adults aged 65 and older enrolled in the Central Control of Mobility in Aging study, 43 were diagnosed with MCR (47% women) based on presence of cognitive complaints and slow gait velocity (MCRv). Four additional subtypes of MCR were defined by substituting slow gait with short stride length (MCRsl, n = 41), slow swing time (MCRsw, n = 21), high stride length variability (MCRslv, n = 24), and high swing time variability (MCRswv, n = 25). The prevalence of clinical gait abnormalities (neurological or non-neurological) in MCR overall (n = 81) and subtypes was studied. We also examined if gait abnormalities predicted further cognitive and functional decline in MCR cases.
Results:
Most clinical gait abnormalities were mild (walked without assistance) in the five MCR subtypes (44 to 61%). Neurological (range 24 to 46%) and non-neurological gait abnormalities (33 to 61%) were common in all MCR subtypes. Neurological gaits were most frequent in MCRsl (46%) and non-neurological gaits in MCRv (61%). Over a median 3.02 years of follow-up, presence of gait abnormality in MCR cases at baseline predicted worsening disability scores (estimate 0.17, p-value = 0.033) but not decline on cognitive scores (p-value = 0.056).
Conclusion:
Clinical gait abnormalities are common in MCR syndrome and its subtypes, and are associated with accelerated functional decline.
DoiT, ShimadaH, MakizakoH, TsutsumimotoK, VergheseJ, SuzukiT (2017) Motoric cognitive risk syndrome: Association with incident dementia and disability. J Alzheimers Dis59, 77–84.
6.
AyersE, VergheseJ (2016) Motoric cognitive risk syndrome and risk of mortality in older adults. Alzheimers Dement12, 556–564.
7.
VergheseJ, HoltzerR, LiptonRB, WangC (2012) Mobility stress test approach to predicting frailty, disability, and mortality in high-functioning older adults. J Am Geriatr Soc60, 1901–1905.
8.
VergheseJ, WangC, LiptonRB, HoltzerR, XueX (2007) Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry78, 929–935.
9.
BuracchioT, DodgeHH, HowiesonD, WassermanD, KayeJ (2010) The trajectory of gait speed preceding mild cognitive impairment. Arch Neurol67, 980–986.
10.
AyersE, VergheseJ (2014) Locomotion, cognition and influences of nutrition in ageing. Proc Nutr Soc73, 302–308.
11.
AllaliG, AyersEI, VergheseJ (2016) Motoric cognitive risk syndrome subtypes and cognitive profiles. J Gerontol A Biol Sci Med Sci71,378–384.
12.
RobertsRO, GedaYE, KnopmanDS, ChaRH, PankratzVS, BoeveBF, TangalosEG, IvnikRJ, RoccaWA, PetersenRC (2012) The incidence of MCI differs by subtype and is higher in men: The Mayo Clinic Study of Aging. Neurology78, 342–351.
13.
SachdevPS, LipnickiDM, CrawfordJ, ReppermundS, KochanNA, TrollorJN, DraperB, SlavinMJ, KangK, LuxO, MatherKA, BrodatyH (2012) Risk profiles of subtypes of mild cognitive impairment: The sydney memory and ageing study. J Am Geriatr Soc60, 24–33.
AllaliG, AyersEI, VergheseJ (2015) Multiple modes of assessment of gait are better than one to predict incident falls. Arch Gerontol Geriatr60, 389–393.
16.
VergheseJ, LiptonRB, HallCB, KuslanskyG, KatzMJ, BuschkeH (2002) Abnormality of gait as a predictor of non-Alzheimer's dementia. N Engl J Med347, 1761–1768.
17.
HoltzerR, MahoneyJR, IzzetogluM, WangC, EnglandS, VergheseJ (2015) Online fronto-cortical control of simple and attention-demanding locomotion in humans. Neuroim-age112, 152–159.
18.
EnglandSE, VergheseJ, MahoneyJR, TrantzasC, HoltzerR (2015) Three-level rating of turns while walking. Gait Posture41, 300–303.
19.
HoltzerR, MahoneyJR, IzzetogluM, IzzetogluK, OnaralB, VergheseJ (2011) fNIRS study of walking and walking while talking in young and old individuals. J Gerontol A Biol Sci Med Sci66, 879–887.
20.
YuanJ, BlumenHM, VergheseJ, HoltzerR (2015) Functional connectivity associated with gait velocity during walking and walking-while-talking in aging: A resting-state fMRI study. Hum Brain Mapp36, 1484–1493.
21.
HoltzerR, WangC, VergheseJ (2014) Performance variance on walking while talking tasks: Theory, findings, and clinical implications. Age (Dordr)36, 373–381.
22.
HoltzerR, VergheseJ, AllaliG, IzzetogluM, WangC, MahoneyJR (2016) Neurological gait abnormalities moderate the functional brain signature of the posture first hypothesis. Brain Topogr29, 334–343.
23.
HoltzerR, VergheseJ, WangC, HallCB, LiptonRB (2008) Within-person across-neuropsychological test variability and incident dementia. JAMA300, 823–830.
24.
VergheseJ, AmbroseAF, LiptonRB, WangC (2010) Neurological gait abnormalities and risk of falls in older adults. J Neurol257,392–398.
25.
VergheseJ, LeValleyA, HallCB, KatzMJ, AmbroseAF, LiptonRB (2006) Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc54,255261.
26.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43, 24122414.
27.
GalvinJE, RoeCM, PowlishtaKK, CoatsMA, MuichSJ, GrantE, MillerJP, StorandtM, MorrisJC (2005) The AD8: A brief informant interview to detect dementia. Neurology65, 559–564.
28.
YesavageJA, BrinkTL, RoseTL, LumO, HuangV, AdeyM, LeirerVO (1982) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res17, 37–49.
29.
LordS, GalnaB, VergheseJ, ColemanS, BurnD, RochesterL (2013) Independent domains of gait in older adults and associated motor and nonmotor attributes: Validation of a factor analysis approach. J Gerontol A Biol Sci Med Sci68, 820–827.
30.
RandolphC, TierneyMC, MohrE, ChaseTN (1998) The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. J Clin Exp Neuropsychol20, 310–319.
31.
HardySE, GillTM (2004) Recovery from disability among community-dwelling older persons. JAMA291, 1596–1602.
32.
FleissJL (2011) Design and analysis of clinical experiments, John Wiley & Sons.
33.
VergheseJ, RobbinsM, HoltzerR, ZimmermanM, WangC, XueX, LiptonRB (2008) Gait dysfunction in mild cognitive impairment syndromes. J Am Geriatr Soc56, 1244–1251.
34.
RosanoC, BrachJ, LongstrethJrWT, NewmanAB (2006) Quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural brain abnormalities in high-functioning older adults. Neuroepi-demiology26, 52–60.
35.
AyersE, LiptonR, VergheseJ (2018) Motoric cognitive risk syndrome: A gait or cognitive syndrome?Alzheimers Dementia14, P972–P973.
36.
BlumenHM, AllaliG, BeauchetO, LiptonRB, VergheseJ (2018) A gray matter volume covariance network associated with the motoric cognitive risk syndrome: A multi-cohort MRI study. J Gerontol A Biol Sci Med Sci, doi:
10.1093/gerona/gly158
PetterssonAF, OlssonE, WahlundLO (2005) Motor function in subjects with mild cognitive impairment and early Alzheimer’s disease. Dement Geriatr Cogn Disord19, 299304.
39.
CosentinoS, BrickmanAM, GriffithE, HabeckC, CinesS, FarrellM, ShakedD, HueyED, BrinerT, SternY (2015) The right insula contributes to memory awareness in cognitively diverse older adults. Neuropsychologia75, 163–169.
40.
MenonV, UddinLQ (2010) Saliency, switching, attention and control: A network model of insula function. Brain Struct Funct214, 655–667.
